Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
13:05
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

53rd ERA-EDTA Congress

 

21-24 May 2016 Vienna
FAQs
   
Discussion forum - 53rd ERA-EDTA Congress
    Topic - Renal pathology. Experimental and clinical.

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 56
Visits: 13
Title: VALUE OF IMMUNOHISTOCHEMICAL EXPRESSION OF PODOCALYXIN IN ACTIVE LUPUS NEPHRITIS
Authors: Maha Behairy , Marwa m. Shakweer , Tamer E. Said
Centre: AIN SHAMS UNIVERSITY ,CAIRO,EGYPT

You must be registered to reply or comment.

VALUE OF IMMUNOHISTOCHEMICAL EXPRESSION OF PODOCALYXIN IN ACTIVE LUPUS NEPHRITIS

Maha Behairy
Thread initiator
Subspeciality
Reg: 4/23/2016 12:13:00 PM
Comment# 1
Podocalyxin is electronegative sialoglycoprotein that prevents podocyte foot process from collapsing. Podocytes loss seems to be a marker for glomerular disease activity or adverse prognosis. We aimed to detect an association between glomerular immunohistochemical (IHC) expression of podocalyxin and the degree of podocyte effacement detected by electron microscopy in patients with lupus nephritis and to evaluate role of IHC expression of podocalyxin as a novel marker for disease activity in lupus nephritis.

Comment added on 4/23/2016 12:13:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 547
Visits: 1241
Title: COMPARISON OF PATIENT HAEMOGLOBIN OUTCOMES WITH WEEKLY IRON ADMINISTRATION VS PER SESSION IRON ADMINISTRATION IN ADULT HAEMODIALYSIS PATIENTS
Authors: Joao Fazendeiro , Ricardo Peralta, Carla Felix, Bruno Pinto, Ilidio Rodrigues, Carlos Oliveira, Anibal Ferreira, Pedro Ponce
Centre: Fresenius Medical Care Portugal

Poster most viewed in this topic
Poster: 71
Visits: 55
Title: APABETALONE (RVX-208), A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, DECREASES ABUNDANCE AND ACTIVITY OF COMPLEMENT PROTEINS IN VITRO, IN MICE AND IN CLINICAL STUDIES
Authors: Norman Wong , Ewelina KulikowskiSylwia WasiakDean GilhamKam Kalantar-ZadehMike Sweeney Jan JohanssonChristopher Halliday
Centre: Resverlogix Corp.


 






PosterSessionOnline
Logo Draft
 
Logo Cert